CNS pipeline · person
Spyridon "Spyros" Papapetropoulos, MD, PhD
President and Chief Executive Officer of Neuphoria Therapeutics (formerly Bionomics) since January 2023, and an executive director on the board. An experienced biopharmaceutical executive and neuroscientist/neurologist with a 25-year career focused on CNS disorders; previously Chief Medical Officer of Vigil Neuroscience, Chief Development Officer and SVP Head of Development at Acadia Pharmaceuticals, CEO of SwanBio Therapeutics, and EVP R&D and CMO at Cavion, with prior senior roles at Biogen, Allergan, Pfizer and Teva. He received his MD and PhD from the University of Patras School of Medicine in Greece.
- 1 company
Courtesy Neuphoria Therapeutics
Current roles
- Neuphoria Therapeutics, Inc.President and Chief Executive Officer · Executive2023–present
- Neuphoria Therapeutics, Inc.Executive Director · Board
Appears with
People sharing a company with Spyridon.
- Alan Fisher · Neuphoria Therapeutics, Inc.
- David Wilson · Neuphoria Therapeutics, Inc.
- Jane Ryan · Neuphoria Therapeutics, Inc.
- Liz Doolin · Neuphoria Therapeutics, Inc.
- Peter Miles Davies · Neuphoria Therapeutics, Inc.
- Tim Cunningham · Neuphoria Therapeutics, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.